 Since then, over 70 monoclonal antibodies have been approved by the FDA.The advancements in biological therapy greatly changed how IBD is treated.Patients with Crohn's disease and ulcerative colitis show an increase in proinflammatory cytokines such as IL-1, IL-6, IL-8, IL-23, and TNF.